Reoperations after gastric banding: replacement or alternative procedures?

Abstract

Laparoscopic reoperation after LAGB is safe and feasible. Reoperation leads to further decrease of BMI and obesity-related comorbidities. Band replacement is a good option for patients with good weight loss after initial LAGB. Alternative procedures, preferably RYGBP, are required for cases of band failure. Overall, RYGBP appears to be the most effective option to induce further weight loss.

Three-dimensional stomach analysis with computed tomography after laparoscopic sleeve gastrectomy: sleeve dilation and thoracic migration

“…Recently, the diversity of bariatric operations has increased remarkably. It has even become possible to variably combine different procedures either primarily or in multistep approaches to enhance weight loss and improve patient outcome [20,21]. Quantitative parameters that can help differentiate physiologic and pathologic changes after surgery are thus ever more desirable.…”

Upper gastrointestinal investigations before gastric banding

“…All the patients were carefully selected, and all received care by a multidisciplinary team consisting of a surgeon, an endocrinologist, and a psychologist. Standard criteria for patient selection described previously were used [6][7][8].…”

“…The perigastric technique was used for 44 (65%) and the pars flaccida technique for 24 (35%) of the 68 patients. The laparoscopic approach, standardized for all the patients, has been described previously [6][7][8]. Hiatal hernias were not repaired at the time of band placement and had no impact on the operative technique.…”

“…Furthermore, the outcome is variable, and the absence of weight loss or regained weight may occur in the long-term postoperative period [6][7][8][9][10].…”

Therapy of Stenosis after Sleeve Gastrectomy: Stent and Surgery as Alternatives – Case Reports

“…tine are suspected and it is regarded as a safe procedure after failed gastric banding [1,2]. This kind of surgery represents not only an alternative for super-obese patients, it is more and more the choice in highest risk patients with severe co-morbidities (e.g.…”